Despite Big Pharma objection, dethroned unicorn Proteus sold in bankruptcy court for $15M

The Redwood City company once promised a revolution in medicine and was valued at $1.5 billion.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.